Skip to main content
Log in

Betamethasone-dipropionate/calcipotriol

Skin irritation: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Wu JJ, et al. Real-world experience of calcipotriene and betamethasone dipropionate foam 0.005%/0.064% in the treatment of adults with psoriasis in the United States. Journal of Dermatological Treatment 30: 454-460, No. 5, 2019. Available from: URL: http://doi.org/10.1080/09546634.2018.1535689 -USA

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Betamethasone-dipropionate/calcipotriol. Reactions Weekly 1761, 81 (2019). https://doi.org/10.1007/s40278-019-64453-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-64453-4

Navigation